Medifast, Inc. (MED)

Medifast Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Quarter	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021
Cash & Equivalents	71.53	89.3	99.53	101.69	91.72	90.93	115.31	108.02	97.47	94.44	112.75	147.41	123.75	87.69	69.71	61.07	118	104.18	154.52	191.99
Short-Term Investments	97.42	77.97	73.99	60.98	72.88	71.42	54.65	55.49	58.96	55.6	45.01	-	-	-	-	-	4.06	5.36	5.38	5.44
Cash & Short-Term Investments	168.95	167.27	173.51	162.67	164.59	162.34	169.96	163.51	156.43	150.04	157.76	147.41	123.75	87.69	69.71	61.07	122.06	109.54	159.9	197.43
Cash Growth	2.65%	3.04%	2.09%	-0.51%	5.22%	8.20%	7.73%	10.92%	26.41%	71.10%	126.31%	141.38%	1.38%	-19.95%	-56.40%	-69.07%	-42.67%	-37.21%	-5.90%	35.79%
Inventory	21.4	20.23	23.21	30.2	39.36	42.42	40.1	39.6	46.27	54.59	58.23	68.9	96.9	118.86	145.28	156.97	188.97	180.04	129.61	95.79
Other Current Assets	12.28	14.18	11.12	13.57	9.57	9.64	14.93	21.21	16.88	19.4	8.29	12.52	9.67	16.24	14.6	25.26	13.23	17.28	11.54	11.1
Total Current Assets	202.63	201.68	207.84	206.44	213.52	214.4	224.98	224.32	219.58	224.03	224.28	228.82	230.32	222.78	229.58	243.3	324.26	306.87	301.05	304.32
Net Property, Plant & Equipment	42.56	38.46	41.24	43.45	46.32	48.68	51.29	53.34	65.52	67.11	69.17	71.11	73.05	75.65	77.93	79.89	80.75	80.59	63.19	55.44
Other Long-Term Assets	6.85	7.83	19.13	19.44	20.17	21.13	14.97	15.88	17.65	18.77	26.58	18.8	18.24	17.78	18.84	17.36	16.43	10.87	7.13	4.48
Total Assets	252.05	247.97	268.21	269.33	280.01	284.21	291.24	293.53	302.76	309.91	320.02	318.73	321.61	316.21	326.35	340.55	421.44	398.33	371.37	364.23
Accounts Payable	38.26	38.36	41.24	40.26	51.82	56.49	66.27	69.15	71.23	86.42	103.22	105.19	113.3	134.69	148.13	154.78	174.37	163.31	155.51	149.02
Short-Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	27	-	-	-	-
Current Portion of Leases	3.92	4.6	5.47	5.92	6.16	6.18	6.11	6.03	5.96	5.89	5.47	5.41	5.41	5.78	6.13	6.38	6.66	6.52	5.4	4.96
Other Current Liabilities	-	-	-	-	2.63	1.49	-	-	-	-	1.42	4.3	13.03	0.43	-	-	-	-	-	-
Total Current Liabilities	42.18	42.96	46.71	46.18	60.6	64.16	72.38	75.18	77.19	92.3	110.11	114.9	131.74	140.89	154.26	188.16	181.03	169.83	160.91	153.98
Long-Term Leases	12.18	6.09	6.79	7.14	8.45	9.94	11.52	13.07	14.61	16.13	16.87	18.27	18.96	20.28	21.57	22.91	24.38	26.02	14.22	15.57
Total Long-Term Liabilities	12.18	6.09	6.79	7.14	8.45	9.94	11.52	13.07	14.61	16.13	16.87	18.27	18.96	20.28	21.57	22.91	24.38	26.02	14.22	15.57
Total Liabilities	54.37	49.05	53.5	53.33	69.05	74.1	83.9	88.25	91.8	108.43	126.98	133.16	150.71	161.17	175.83	211.07	205.41	195.85	175.13	169.55
Common Stock	0.01	0.01	0.01	0	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Treasury Stock	-	-	-	-	-	-	-	-	-	-	-	-	-	-6.4	-	-	-	-	-	-1.35
Additional Paid-in Capital	41.49	40.41	38.23	37.32	34.7	33.14	31.01	30.4	27.96	26.57	24.11	21.54	19.03	21.56	18.62	-	12.83	12.02	12.95	10.61
Accumulated Other Comprehensive Income	0.03	0.23	0.22	0.18	0.24	0.18	0.35	0.03	0.02	0.25	0.14	0.12	0.03	0.02	0.39	0.27	0.13	0.11	0.12	0.08
Retained Earnings	156.15	158.27	176.24	178.49	176.01	176.78	175.98	174.85	182.97	174.65	168.78	163.89	151.83	139.85	131.5	129.2	203.05	190.33	183.16	185.34
Shareholders' Equity	197.68	198.92	214.71	216.01	210.96	210.11	207.34	205.28	210.96	201.48	193.04	185.56	170.9	155.04	150.52	129.48	216.02	202.47	196.24	194.69
Total Liabilities & Equity	252.05	247.97	268.21	269.33	280.01	284.21	291.24	293.53	302.76	309.91	320.02	318.73	321.61	316.21	326.35	340.55	421.44	398.33	371.37	364.23
Total Debt	16.1	10.69	12.26	13.07	14.61	16.13	17.63	19.1	20.57	22.01	22.34	23.67	24.38	26.05	27.7	56.29	31.04	32.54	19.62	20.52
Net Cash (Debt)	152.85	156.58	161.25	149.61	149.98	146.22	152.33	144.41	135.86	128.03	135.42	123.73	99.37	61.64	42.01	4.78	91.02	77	140.27	176.9
Net Cash Growth	1.91%	7.08%	5.86%	3.60%	10.40%	14.21%	12.49%	16.71%	36.72%	107.70%	222.34%	2490.14%	9.18%	-19.95%	-70.05%	-97.30%	-55.09%	-52.85%	-11.12%	32.63%
Net Cash Per Share	13.89	14.25	14.67	13.53	13.70	13.31	13.88	13.20	12.40	11.71	12.39	11.33	9.12	5.61	3.81	0.42	7.82	6.58	11.90	14.92
Book Value	197.68	198.92	214.71	216.01	210.96	210.11	207.34	205.28	210.96	201.48	193.04	185.56	170.9	155.04	150.52	129.48	216.02	202.47	196.24	194.69
Book Value Per Share	17.96	18.10	19.53	19.53	19.27	19.13	18.90	18.77	19.25	18.43	17.66	17.00	15.68	14.10	13.63	11.32	18.56	17.31	16.65	16.42
Tangible Book Value	197.68	198.92	214.71	216.01	210.96	210.11	207.34	205.28	210.96	201.48	193.04	185.56	170.9	155.04	150.52	129.48	216.02	202.47	196.24	194.69
Tangible Book Value Per Share	17.96	18.10	19.53	19.53	19.27	19.13	18.90	18.77	19.25	18.43	17.66	17.00	15.68	14.10	13.63	11.32	18.56	17.31	16.65	16.42

Updated May 4, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q